Upregulation of matrix metalloproteinases following nerve injury is not mediated by mast cell activation

NeuroImmunoModulation

Volumn 12, Issue 4, 2005, Pages 211-219

  Zuo, Yun Xia ^a,b   Tracey, David J ^a   Geczy, Carolyn ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Gelatinase; Mast cells; Matrix metalloproteinases; Nerve injury

Indexed keywords

CROMOGLYCATE DISODIUM; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEGENERATION; MALE; MAST CELL; NERVE INJURY; NERVE LIGATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; UPREGULATION; ZYMOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INFLAMMATION; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; RATS; RATS, WISTAR; SCIATIC NERVE; SCIATIC NEUROPATHY; UP-REGULATION; WALLERIAN DEGENERATION;

EID: 21344458599     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085653     Document Type: Article

References (43)

1. Kieseier BC, Seifert T, Giovannoni G, Hartung HP: Matrix metalloproteinases in inflammatory demyelination: Targets for treatment. Neurology 1999;53:20-25.
2. Platt CI, Krekoski CA, Ward RV, Edwards DR, Gavrilovic J: Extracellular matrix and matrix metalloproteinases in sciatic nerve. J Neurosci Res 2003;74:417-429.
3. Hughes PM, Wells GMA, Perry VH, Brown MC, Miller KM: Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 2002;113:273-287.
4. Shubayev VI, Myers RR: Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000;855:83-89.
5. Siebert H, Dippel N, Mader M, Weber F, Bruck W: Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol 2001;60:85-93.
6. Keck T, Balcom JH, Fernandez-Del Castillo C, Antoniu BA, Warshaw AL: Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002;122:188-201.
7. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
8. Sommer C, Schmidt C, George A, Toyka KV: A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1997;237:45-48.
9. Skaper SD, Pollock M, Facci L: Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res Mol Brain Res 2001;97:177-185.
10. Xiang Z, Nilsson G: IgE receptor-mediated release of nerve growth factor by mast cells. Clin Exp Allergy 2000;30:1379-1386.
11. Gordon JR: TGFbeta1 and TNFalpha secreted by mast cells stimulated via the FcepsilonRI activate fibroblasts for high-level production of monocyte chemoattractant protein-1 (MCP-1). Cell Immunol 2000;201:42-49.
12. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997;77:1033-1079.
13. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS: Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol 2002;283:H518-H525.
14. Fang KC, Raymond WW, Blount JL, Caughey GH: Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 1997;272:25628-25635.
15. Chancey AL, Brower GL, Janicki JS: Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am J Physiol 2002;282:H2152-H2158.
16. Murray DB, Gardner JD, Brower GL, Janicki JS: Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation and myocardial remodeling in rats. Am J Physiol 2004;287:H2295-H2299.
17. Seltzer Z, Dubner R, Shir Y: A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43:205-218.
18. Zuo Y-X, Perkins NM, Tracey DJ, Geczy CL: Inflammation and hyperalgesia induced by nerve injury in the rat: A key role of mast cells. Pain 2003;105:467-479.
19. Orr TS, Cox JS: Disodium cromoglycate, an inhibitor of mast cell degranulation and histamine release induced by phospholipase A. Nature 1969;223:197-198.
20. Patalano F, Ruggieri F: Sodium cromoglycate: A review. Eur Respir J Suppl 1989;6:556s-560s.
21. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D: Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998;18:1035-1045.
22. Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D: Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 1997;150:653-666.
23. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
24. Kherif S, Dehaupas M, Lafuma C, Fardeau M, Alameddine HS: Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve. Neuropathol Appl Neurobiol 1998;24:309-319.
25. Bannikov GA, Karelina TV, Collier IE, Marmer BL, Goldberg GI: Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 2002;277:16022-16027.
26. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-697.
27. La Fleur M, Underwood JL, Rappolee DA, Werb Z: Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 1996;184:2311-2326.
28. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA: Human mast cells release metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-alpha. J Immunol 2001;167:4008-4016.
29. Nguyen M, Arkell J, Jackson CJ: Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001;33:960-970.
30. Saren P, Welgus HG, Kovanen PT: TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996;157:4159-4165.
31. George A, Schmidt C, Weishaupt A, Toyka KV, Sommer C: Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 1999;160:124-132.
32. Overall CM, Sodek J: Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J Biol Chem 1990;265:21141-21151.
33. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V: Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002;160:673-680.
34. Muir D: Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metastasis 1995;13:303-314.
35. Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 1990;50:6184-6191.
36. Giraudon P, Buart S, Bernard A, Belin MF: Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes. Mol Psychiatry 1997;2:107-110, 184.
37. Yu AE, Murphy AN, Stetler-Stevenson WG: 72-kDa Gelatinase (Gelatinase A): Structure, Activation, Regulation, and Substrate Specificity; in Parks WC, Mecham RP (eds): Matrix Metalloproteinases. San Diego, Academic Press, 1998, pp 85-113.
38. Hu P, McLachlan EM: Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 2002;112:23-38.
39. Ruohonen S, Jagodi M, Khademi M, Taskinen HS, Ojala P, Olsson T, Roytta M: Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10. J Neuroimmuno1 2002;132:11-17.
40. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR: Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003;23:1026-1040.
41. Fang KC, Raymond WW, Lazarus SC, Caughey GH: Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 1996;97:1589-1596.
42. Sopata I, Wojtecka-Lukasik E, MaSlinski S: Activation of latent human granulocyte gelatinase by rat mast cell protease. Folia Histochem Cytobiol 1986;24:133-137.
43. Shamash S, Reichert F, Rotshenker S: The cytokine network of Wallerian degeneration: Tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002;22:3052-3060.